209 related articles for article (PubMed ID: 21463549)
1. Diagnostic and prognostic value of the methylation status of secreted frizzled-related protein 2 in colorectal cancer.
Tang D; Liu J; Wang DR; Yu HF; Li YK; Zhang JQ
Clin Invest Med; 2011 Apr; 34(2):E88-95. PubMed ID: 21463549
[TBL] [Abstract][Full Text] [Related]
2. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
Huang Z; Li L; Wang J
Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
[TBL] [Abstract][Full Text] [Related]
4. Hypermethylated SFRP2 gene in fecal DNA is a high potential biomarker for colorectal cancer noninvasive screening.
Wang DR; Tang D
World J Gastroenterol; 2008 Jan; 14(4):524-31. PubMed ID: 18203283
[TBL] [Abstract][Full Text] [Related]
5. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
[TBL] [Abstract][Full Text] [Related]
6. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation of SFRP1, SFRP2, and WIF1 and prognosis of postoperative colorectal cancer patients.
Liu X; Fu J; Bi H; Ge A; Xia T; Liu Y; Sun H; Li D; Zhao Y
BMC Cancer; 2019 Dec; 19(1):1212. PubMed ID: 31830937
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation analysis of secreted frizzled-related protein 2 gene for the early detection of colorectal cancer in fecal DNA.
Babaei H; Mohammadi M; Salehi R
Niger Med J; 2016; 57(4):242-5. PubMed ID: 27630389
[TBL] [Abstract][Full Text] [Related]
9. Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes are Associated with Colorectal Cancer.
Hu H; Wang T; Pan R; Yang Y; Li B; Zhou C; Zhao J; Huang Y; Duan S
Pathol Oncol Res; 2019 Apr; 25(2):567-575. PubMed ID: 30368728
[TBL] [Abstract][Full Text] [Related]
10. Variation risks of SFRP2 hypermethylation between precancerous disease and colorectal cancer.
Sui C; Wang G; Chen Q; Ma J
Tumour Biol; 2014 Oct; 35(10):10457-65. PubMed ID: 25053594
[TBL] [Abstract][Full Text] [Related]
11. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
[TBL] [Abstract][Full Text] [Related]
12. Sensitive and Noninvasive Detection of Aberrant SFRP2 and MGMT-B Methylation in Iranian Patients with Colon Polyps.
Naini MA; Mokarram P; Kavousipour S; Zare N; Atapour A; Zarin1 MH; Mehrabani G; Borji M
Asian Pac J Cancer Prev; 2016; 17(4):2185-93. PubMed ID: 27221916
[TBL] [Abstract][Full Text] [Related]
13. Performance of a MethyLight assay for methylated SFRP2 DNA detection in colorectal cancer tissue and serum.
Li H; Wang Z; Zhao G; Ma Y; Chen Y; Xue Q; Zheng M; Fei S
Int J Biol Markers; 2019 Mar; 34(1):54-59. PubMed ID: 30852954
[TBL] [Abstract][Full Text] [Related]
14. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.
Chang E; Park DI; Kim YJ; Kim BK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim HD; Kim DH; Kim YH
Hepatogastroenterology; 2010; 57(101):720-7. PubMed ID: 21033217
[TBL] [Abstract][Full Text] [Related]
15. [Value of combined detection of ITGA4 and SFRP2 gene methylation in stool DNA in diagnosis and prognostic evaluation of colorectal tumors].
Jin H; Pang L; Li H; Xu M; Yan H; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jun; 41(6):891-897. PubMed ID: 34238742
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA.
Lu H; Huang S; Zhang X; Wang D; Zhang X; Yuan X; Zhang Q; Huang Z
Oncol Lett; 2014 Oct; 8(4):1751-1756. PubMed ID: 25202404
[TBL] [Abstract][Full Text] [Related]
17. Detection of aberrant methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions.
Huang ZH; Li LH; Yang F; Wang JF
World J Gastroenterol; 2007 Feb; 13(6):950-4. PubMed ID: 17352030
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of secreted frizzled-related protein 2 gene promoter hypermethylation in stool for colorectal cancer: A meta-analysis.
Zhou Z; Zhang H; Lei Y
J Cancer Res Ther; 2016 Oct; 12(Supplement):30-33. PubMed ID: 27721248
[TBL] [Abstract][Full Text] [Related]
19. A novel plasma based early colorectal cancer screening assay base on methylated SDC2 and SFRP2.
Zhao G; Ma Y; Li H; Li S; Zhu Y; Liu X; Xiong S; Liu Y; Miao J; Fei S; Zheng M; Zhao X
Clin Chim Acta; 2020 Apr; 503():84-89. PubMed ID: 31962098
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a prototype reverse hybridization assay and MethyLight for detection of SFRP2 promotor methylation in fecal DNA.
Kriegshäuser G; Enko D; Zitt M; Oberwalder M; Oberkanins C; Öfner D; Zeillinger R; Maximilian Müller H
Int J Biol Markers; 2017 Oct; 32(4):e467-e470. PubMed ID: 28777432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
